AbbVie in Podcasts
companyAbbVie, a pharmaceutical company that acquired Gilgamesh, a company developing psychedelic compounds.
Mentions Over Time
2
mentions
Mentions in Podcasts
Wall Street Breakfast
Earnings season begins as Trump threatens Hormuz blockade
And for income investors, Abbott Labs and AbbVie go ex-dividend on Wednesday with payouts scheduled for May 15th.
Motley Fool Money
The Psychedelic Revolution
And there was a high-profile acquisition in, I think it was August of last year, when Gilgamesh was bought by AbbVie on the basis of a psychedelic compound that's called Brettosilicin.